Revolutionary Cancer Treatment Unveiled in Casablanca
On March 12, 2026, a significant milestone was achieved in the realm of medical innovation at Oncorad Group’s Le Littoral Clinic in Ain Diab, Casablanca. This marked the first time a groundbreaking tumor treatment, previously unseen in Africa, has been implemented, showcasing the clinic's commitment to advancing healthcare on the continent. The pioneering procedure integrates cutting-edge cryotherapy with high-precision Positron Emission Tomography (PET) scanning, offering patients a highly targeted and safe treatment directly aimed at their tumors.
The unique protocol employed in this treatment involves the accurate localization of the tumor using the PET scanner, followed by its destruction through cryotherapy performed by an interventional radiologist. Additionally, a nuclear medicine physician ensures in real-time that the lesion has been completely eradicated. This innovative approach not only enhances the effectiveness of tumor treatment but also instills hope for patients suffering from various types of cancers across Africa.
The first patient to benefit from this pioneering technology had a tumor located on the scapula, symbolizing the dawn of a new era in oncological care in Morocco and beyond. To achieve this remarkable feat, Oncorad Group assembled an interdisciplinary team consisting of interventional radiologist Dr. Mrani Zentar Alae, nuclear medicine physician Dr. Shimi Younes, and anesthesiologist Dr. Belkadi Kamal. They utilized a state-of-the-art PET scanner, the only one of its kind in Morocco, which incorporates artificial intelligence to enhance diagnostic accuracy.
Dr. Mrani expressed the significance of this achievement, stating, "We are witnessing a genuine medical revolution, taking a historic step in Africa. This technology is now accessible to patients at the Le Littoral Clinic in Casablanca." This exceptional advancement aligns with Oncorad Group’s mission to position Morocco as a leader in medical innovation, striving to make tomorrow's medicine accessible to all Moroccans.
About Oncorad Group
Founded in 2000 by Pr. Redouane Samlali and Dr. Omar Hajji, Oncorad Group has established itself as a trailblazer in the field of medical innovation within Morocco's private sector. Initially focused on oncology, the group has evolved into a multidisciplinary excellence model, incorporating cutting-edge technologies to enhance diagnosis, treatment, and patient follow-up. The synergy of the group spans several medical disciplines, including advanced imaging, medical oncology, state-of-the-art radiotherapy, neonatal intensive care, robotic surgery, nuclear medicine, and other specialties, all unified by top-tier innovative equipment. This comprehensive approach allows for personalized, swift, precise, and well-coordinated care, with a clear ambition to make the medicine of tomorrow accessible to every Moroccan.
As reported by infomediaire.net.
